Ampath Labs is a diagnostic pathology portal for patients in India to book home phlebotomy and manage test orders on iOS.
The App DNA
What makes this app unique?
The service removes the logistical friction of visiting a physical laboratory for routine and specialized diagnostic testing.
For Patients in India requiring routine or specialized diagnostic pathology services, including those seeking home-based sample collection.
What does it look like?
Key features
Users schedule phlebotomy services at their residence via the app interface, increasing conversion of high-value health check packages.
Users submit diagnostic test prescriptions for processing, reducing friction for complex test orders.
Bundled diagnostic tests categorized by condition or lifestyle, increasing average transaction size.
How much does it cost?
The app functions as a transactional portal for laboratory services with individual test pricing starting at ₹66 and packages up to ₹1919.
Velocity
Maintenance developmentUX improvementsShow more...
Ampath Labs maintains a low-frequency release cadence, with only one update shipped in the last 75 days. Development is currently limited to minor interface adjustments, with no evidence of new feature rollouts or live-service events. The current pace of approximately 0.09 releases per week places the app firmly in a maintenance cycle. Future development appears focused on incremental polish rather than significant functional expansion.
Who built it?
American Institute Of Pathology And Laboratory Sciences Private
1 app tracked · Medical
Explore the full publisher profileUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Ampath Labs
How's the Medical market?
Ampath Labs serves the Indian diagnostic market with a specialized test catalog of 2600+ items. The lack of recent feature updates suggests a focus on physical lab operations over digital growth, leaving the platform exposed to competitors with higher release velocities.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Ampath Labs
Where is it heading?
The Indian diagnostic market is shifting toward digital-first experiences that prioritize speed and transparency. Ampath Labs remains stable due to its physical laboratory accreditation, but the lack of digital iteration creates a long-term churn risk as patients migrate to platforms with better booking and result-tracking features.
- The maintenance-only release cadence suggests a focus on operational stability rather than aggressive digital expansion, limiting potential for rapid user growth.
The SWOT
- NABL-accredited laboratory network sustains quality-driven trust
- 2600+ test catalog functions as a comprehensive diagnostic barrier
- Integrating longitudinal health tracking would increase repeat transaction frequency
Next best moves
Ship automated status notifications because current manual booking lacks real-time updates → increase repeat usage
The counter-intuitive read
The lack of digital innovation is a deliberate…
Read the full takeSince the last report: Ampath Labs has formalized its competitive position by highlighting a 2600+ test catalog, providing a clearer differentiator against diagnostic aggregators. The core operational posture remains in a maintenance cycle with no functional updates to the booking flow.
Bottom line
Ampath Labs relies on its physical laboratory accreditation to retain users, but the stagnant update cadence leaves it vulnerable to digital-first competitors. Prioritizing a feature refresh to improve the booking flow would defend the current user base against more agile diagnostic platforms.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated